Overview
Mirago Tablets ER contain Mirabegron 50 mg, an extended-release beta-3 adrenergic receptor agonist used to treat symptoms of overactive bladder (OAB) such as urinary urgency, frequency, and urge incontinence. Mirabegron works by relaxing the detrusor muscle in the bladder, increasing bladder capacity and reducing the frequency of urination.





